Topic: antibiotic resistance
India’s Wockhardt has built a $40 million manufacturing facility in the Middle East to make drug-resistant antibiotics.
Achaogen shares slipped Tuesday after the FDA slapped brand-new Zemdri with a black-box warning and nixed a second indication it hoped to gain.
Novasep, which makes clinical supplies for a new antibiotic being developed by Tetraphase, will now start commercial-scale production.
Already reeling from bad news on its dengue shot, Sanofi canned its phase 3 C. diff vaccine—and the $500 million-plus in sales that might have come with it.
No currently available vaccines against typhoid are meant for children younger than 2, but a new WHO endorsement could change that.
Drug regulators from Europe, the U.S. and Japan formed an antibiotic alliance; SK Biotek purchased an API plant by BMS; JSR nabs Selexis.
An upstate New York maker of antibiotics has scored some government incentives to help cover the cost of expanding its plant in Syracuse.
Pfizer new Antimicrobial Testing Leadership and Surveillance, or ATLAS, system offers global antibiotic resistance data with user-friendly website along with a mobile app version.
Scientists have been saying for years that polluting pharma plants are directly contributing to the spread of antibiotic resistance. Now, it looks as if they could have hard evidence in India, the world's biggest antibiotic producer.
More than a dozen pharmaceutical companies from Big Pharma players to CMOs have agreed to take steps to fight antibiotic resistance including reviewing their manufacturing and supply chains.